• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内科住院癌症患者静脉血栓栓塞风险分层。综合癌症中心的经验。

Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience.

机构信息

Division of Hematology and Medical Oncology, Department of Internal Medicine, King Hussein Cancer Center, Queen Rania Al Abdullah Street, PO Box 1269, Amman 11941, Jordan,

出版信息

J Thromb Thrombolysis. 2010 Oct;30(3):286-93. doi: 10.1007/s11239-010-0445-9.

DOI:10.1007/s11239-010-0445-9
PMID:20127272
Abstract

Cancer and its treatment are recognized risk factors for VTE. Compliance rate with published VTE prophylaxis guidelines is low. Decision on when to offer prophylaxis for hospitalized cancer patients is difficult to make. This paper describes current clinical practice in offering VTE prophylaxis to hospitalized cancer patients. Prophylaxis rate and rate of VTE will be correlated with the risk level. We prospectively followed all consecutive adult cancer patients admitted to medical units over a 5-month period. Caprini risk assessment model, with some modifications, was utilized to determine risk of VTE. Six hundred and six patients (51% males, median age 52 years, range 18-91) were included. Reasons for admission included infections (25%), chemotherapy (22%) and palliative care (10%). In addition to cancer, the most frequently encountered risk factors for VTE were: Immobilization (35%), age > 60 years (31%) and body mass index > 30 in (20%). Patients were grouped according to their total risk score: low (9%), moderate (44%) and high risk (47%). VTE prophylaxis rate was 55.1% for the whole study group. Following discharge, patients were followed for 60 days. The incidence of VTE was 3.4% in the moderate and 4.2% in the high risk groups, while none in the low risk group developed VTE. Many additional risk factors for VTE are usually encountered in hospitalized cancer patients. Cancer alone may not be an enough reason for VTE prophylaxis. Risk assessment model able to stratify patients into different risk categories will simplify decision making and enhance VTE prophylaxis rate.

摘要

癌症及其治疗被认为是 VTE 的风险因素。发表的 VTE 预防指南的依从率很低。对于住院癌症患者何时提供预防措施的决策非常困难。本文描述了为住院癌症患者提供 VTE 预防的当前临床实践。预防率和 VTE 发生率将与风险水平相关。我们前瞻性地随访了在 5 个月期间入住内科病房的所有连续成年癌症患者。利用经一些修改的 Caprini 风险评估模型来确定 VTE 的风险。共纳入 606 例患者(51%为男性,中位年龄为 52 岁,范围为 18-91 岁)。入院的原因包括感染(25%)、化疗(22%)和姑息治疗(10%)。除癌症外,VTE 的最常见危险因素还包括:固定不动(35%)、年龄 > 60 岁(31%)和 BMI > 30(20%)。根据患者的总风险评分将患者分为低危(9%)、中危(44%)和高危(47%)三组。整个研究组的 VTE 预防率为 55.1%。出院后,对患者进行了 60 天的随访。中危组和高危组的 VTE 发生率分别为 3.4%和 4.2%,而低危组无一例发生 VTE。住院癌症患者通常还存在许多其他 VTE 危险因素。单纯癌症可能不是 VTE 预防的充分理由。能够对患者进行分层的风险评估模型将简化决策并提高 VTE 预防率。

相似文献

1
Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience.内科住院癌症患者静脉血栓栓塞风险分层。综合癌症中心的经验。
J Thromb Thrombolysis. 2010 Oct;30(3):286-93. doi: 10.1007/s11239-010-0445-9.
2
Overuse of venous thromboembolism prophylaxis among hospitalized patients with liver disease.住院肝病患者静脉血栓栓塞症预防过度。
Eur J Haematol. 2020 Mar;104(3):223-229. doi: 10.1111/ejh.13363. Epub 2020 Jan 19.
3
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.内科疾病患者的静脉血栓栓塞症延伸预防:NATF 抗凝行动倡议。
Am J Med. 2020 May;133 Suppl 1:1-27. doi: 10.1016/j.amjmed.2019.12.001.
4
Incidence of Venous Thromboembolism, Risk Factors and Prophylaxis in Hospitalized Patients in the South West Region of Cameroon.喀麦隆西南地区住院患者静脉血栓栓塞的发病率、危险因素及预防
Vasc Health Risk Manag. 2020 Jul 22;16:317-324. doi: 10.2147/VHRM.S205935. eCollection 2020.
5
Venous thromboembolism (VTE) in hospitalized cancer patients: prophylaxis failure or failure to prophylax!住院癌症患者的静脉血栓栓塞症 (VTE):预防失败还是未预防!
J Thromb Thrombolysis. 2011 Jan;31(1):107-12. doi: 10.1007/s11239-010-0509-x.
6
Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.比较 Khorana 预测评分和 Caprini 风险评估模型在评估住院癌症患者静脉血栓栓塞风险中的应用:一项回顾性病例对照研究。
Interact Cardiovasc Thorac Surg. 2020 Oct 1;31(4):454-460. doi: 10.1093/icvts/ivaa137.
7
Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy.Caprini 风险评估模型在接受乳房切除术患者中预防静脉血栓栓塞症的应用
Ann Surg Oncol. 2018 Nov;25(12):3548-3555. doi: 10.1245/s10434-018-6696-y. Epub 2018 Aug 20.
8
Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.静脉血栓栓塞风险与住院内科患者的预防。ENDORSE 全球调查。
Thromb Haemost. 2010 Apr;103(4):736-48. doi: 10.1160/TH09-09-0667. Epub 2010 Feb 2.
9
Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.成年癌症患者群体中静脉血栓栓塞预防措施的回顾性评估。
J Oncol Pharm Pract. 2010 Mar;16(1):27-31. doi: 10.1177/1078155209104379. Epub 2009 Apr 28.
10
Venous thromboembolism risk and prophylaxis prescription in surgical patients at a tertiary hospital in Eastern Cape Province, South Africa.南非东开普省一家三级医院外科手术患者的静脉血栓栓塞风险和预防处方。
S Afr Med J. 2019 Feb 26;109(3):178-181. doi: 10.7196/SAMJ.2019.v109i3.13510.

引用本文的文献

1
Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis.医院住院患者静脉血栓栓塞风险评估模型的评估:VTEAM 证据综合评价。
Health Technol Assess. 2024 Apr;28(20):1-166. doi: 10.3310/AWTW6200.
2
Systematic review of venous thromboembolism risk categories derived from Caprini score.基于 Caprini 评分的静脉血栓栓塞风险分类的系统评价。
J Vasc Surg Venous Lymphat Disord. 2022 Nov;10(6):1401-1409.e7. doi: 10.1016/j.jvsv.2022.05.003. Epub 2022 Aug 2.
3
Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review.

本文引用的文献

1
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology.静脉血栓栓塞性疾病。美国国立综合癌症网络。肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2008 Sep;6(8):716-53. doi: 10.6004/jnccn.2008.0055.
2
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).静脉血栓栓塞的预防:美国胸科医师学会循证临床实践指南(第8版)
Chest. 2008 Jun;133(6 Suppl):381S-453S. doi: 10.1378/chest.08-0656.
3
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).
住院成年患者静脉血栓栓塞症风险评估模型:系统评价。
BMJ Open. 2021 Jul 29;11(7):e045672. doi: 10.1136/bmjopen-2020-045672.
4
Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews.住院内科患者静脉血栓栓塞症和出血风险评估模型:系统评价概述。
Blood Adv. 2020 Oct 13;4(19):4929-4944. doi: 10.1182/bloodadvances.2020002482.
5
Risk Assessment in Chinese Hospitalized Patients Comparing the Padua and Caprini Scoring Algorithms.中国住院患者的风险评估:比较 Padua 和 Caprini 评分算法。
Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):127S-135S. doi: 10.1177/1076029618797465. Epub 2018 Sep 9.
6
Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model.采用 Padua 预测评分和 Caprini 风险评估模型评估住院患者静脉血栓栓塞风险。
J Atheroscler Thromb. 2018 Nov 1;25(11):1091-1104. doi: 10.5551/jat.43653. Epub 2018 Mar 13.
7
The Application of Current Proposed Venous Thromboembolism Risk Assessment Model for Ambulatory Patients With Cancer.当前提议的静脉血栓栓塞风险评估模型在癌症门诊患者中的应用
Clin Appl Thromb Hemost. 2018 Apr;24(3):429-433. doi: 10.1177/1076029617692880. Epub 2017 Feb 9.
8
Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis.癌症患者静脉血栓栓塞风险:系统评价和荟萃分析。
PLoS Med. 2012;9(7):e1001275. doi: 10.1371/journal.pmed.1001275. Epub 2012 Jul 31.
9
Venous thromboembolism (VTE) in hospitalized cancer patients: prophylaxis failure or failure to prophylax!住院癌症患者的静脉血栓栓塞症 (VTE):预防失败还是未预防!
J Thromb Thrombolysis. 2011 Jan;31(1):107-12. doi: 10.1007/s11239-010-0509-x.
血浆中可溶性P选择素水平升高可预测癌症患者发生静脉血栓栓塞:维也纳癌症与血栓形成研究(CATS)的结果
Blood. 2008 Oct 1;112(7):2703-8. doi: 10.1182/blood-2008-02-142422. Epub 2008 Jun 6.
4
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study.急性医院护理环境中的静脉血栓栓塞风险与预防(ENDORSE研究):一项跨国横断面研究。
Lancet. 2008 Feb 2;371(9610):387-94. doi: 10.1016/S0140-6736(08)60202-0.
5
Development and validation of a predictive model for chemotherapy-associated thrombosis.化疗相关性血栓形成预测模型的开发与验证
Blood. 2008 May 15;111(10):4902-7. doi: 10.1182/blood-2007-10-116327. Epub 2008 Jan 23.
6
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.美国临床肿瘤学会指南:癌症患者静脉血栓栓塞预防和治疗的建议
J Clin Oncol. 2007 Dec 1;25(34):5490-505. doi: 10.1200/JCO.2007.14.1283. Epub 2007 Oct 29.
7
Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.急性病住院内科患者的静脉血栓栓塞预防:国际静脉血栓栓塞医学预防登记研究的结果
Chest. 2007 Sep;132(3):936-45. doi: 10.1378/chest.06-2993. Epub 2007 Jun 15.
8
Incidence of venous thromboembolism and the impact on survival in breast cancer patients.乳腺癌患者静脉血栓栓塞的发生率及其对生存的影响。
J Clin Oncol. 2007 Jan 1;25(1):70-6. doi: 10.1200/JCO.2006.07.4393.
9
A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: incidence of symptomatic thromboembolism and description of thromboprophylaxis practices.一项针对患有急性医疗事件且活动能力下降的门诊患者队列的前瞻性观察研究:症状性血栓栓塞的发生率及血栓预防措施描述。
J Intern Med. 2006 Aug;260(2):168-76. doi: 10.1111/j.1365-2796.2006.01678.x.
10
Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.近期活动能力下降的急性病内科患者的延长疗程血栓预防:EXCLAIM研究方法
J Thromb Thrombolysis. 2006 Aug;22(1):31-8. doi: 10.1007/s11239-006-7732-5.